Using machine learning to discriminate non-classical 21-hydroxylase deficiency from polycystic ovary syndrome: an external validation study
Clicks: 16
ID: 320194
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
16 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #15 of 91 articles by views in european journal of endocrinology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
INTRODUCTION: Nonclassical 21-hydroxylase deficiency (NC21OHD) is a rare autosomal recessive disorder that is frequently misdiagnosed as polycystic ovary syndrome (PCOS) because of their overlapping clinical and biochemical presentations. The conventional diagnostic method, the cosyntropin stimulation test, is invasive, time-consuming, and difficult to implement in routine clinical practice. To overcome these limitations, we previously developed a proof-of-concept machine learning model integrating basal serum steroid profiling by LC-MS/MS to identify NC21OHD without the need for dynamic stimulation testing. The present study aimed to validate and refine this model in a larger, multicentric cohort to evaluate its diagnostic performance in distinguishing NC21OHD from PCOS based on baseline steroid signatures. METHODS: This tricentric study included 447 women: 263 with PCOS and 59 with NC21OHD in the training set (Pitié-Salpêtrière Hospital, Paris), and 104 PCOS and 21 NC21OHD in two independent validation cohorts (Saint-Antoine Hospital, Paris; Bordeaux University Hospital). Twenty serum steroids were quantified by LC-MS/MS and analyzed using orthogonal partial least squares discriminant analysis (OPLS-DA). Model robustness was assessed by internal cross-validation and external validation. RESULTS: 20-steroid model achieved complete separation between NC21OHD and PCOS in both external validation cohorts (accuracy = 100%). The most discriminant metabolites were 21-deoxycortisone (21-DE), 21-deoxycortisol (21-DF), and 17-hydroxyprogesterone (17OHP). Simplified 3- and 6-steroid models demonstrated reduced sensitivity (∼90%) and specificity (∼97%). CONCLUSION: Machine learning combined with basal LC-MS/MS steroid profiling enables accurate identification of NC21OHD without dynamic stimulation. This approach could simplify diagnosis, improve patient comfort, and support large-scale screening of hyperandrogenic women.
| Reference Key |
openalex_W7167575190
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tatiana Lecot‐Connan, Guillaume Bachelot, B Donadille, C Sayed, Jacques Young, J Fiet, C Bellanné-Chantelot, Virginie Grouthier, Sophie Christin‐Maître, A Bachelot, Antonin Lamazière |
| Journal | european journal of endocrinology |
| Year | 2026 |
| DOI |
10.1093/ejendo/lvag114
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.